V029-2839 Screening compound: 1-[4-(4-fluorophenoxy)-6-[(3-methylthiophen-2-yl)methyl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]-4-methylpiperazine

V029-2839 Screening compound: 1-[4-(4-fluorophenoxy)-6-[(3-methylthiophen-2-yl)methyl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]-4-methylpiperazine
V029-2839 Screening compound: 1-[4-(4-fluorophenoxy)-6-[(3-methylthiophen-2-yl)methyl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]-4-methylpiperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-2839
1-[4-(4-fluorophenoxy)-6-[(3-methylthiophen-2-yl)methyl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]-4-methylpiperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-2839

Molecular Formula

C24H28FN5OS (C24 H28 FN5 OS)

Compound Name

1-[4-(4-fluorophenoxy)-6-[(3-methylthiophen-2-yl)methyl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]-4-methylpiperazine

IUPAC name

1-[4-(4-fluorophenoxy)-6-[(3-methylthiophen-2-yl)methyl]-5H6H7H8H-pyrido[43-d]pyrimidin-2-yl]-4-methylpiperazine

SMILES

Cc1c(CN(CCc2nc(N3CCN(C)CC3)n3)Cc2c3Oc(cc2)ccc2F)scc1

InChI

InChI=1S/C24H28FN5OS/c1-17-8-14-32-22(17)16-29-9-7-21-20(15-29)23(31-19-5-3-18(25)4-6-19)27-24(26-21)30-12-10-28(2)11-13-30/h3-6,8,14H,7,9-13,15-16H2,1-2H3

InChI Key

KISXVCXDIKOHOQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19932464

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

453.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.766

Distribution Coefficient, logD

4.194

Water Solubility, LogSw

-4.47

Polar Surface Area

38.085

Acid Dissociation Constant (pKa)

20.58

Base Dissociation Constant (pKb)

7.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

V029-2839 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

BRD4 Targeted Library (4534 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
Targets:
  • Others

References: we are preparing a list of scientific research reports with V029-2839 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-2839?
Check Price and Availability of V029-2839, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-2839 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-2839
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-2839
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-2839 available by request